Ethotoin

CHEMBL1095 Phase 4 Disetujui Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

204.2 g/mol

LogP

1.0

Phase

4

This hydantoin anticonvulsant stabilizes nerve cell membranes to reduce the spread of abnormal electrical activity that causes seizures. It is used to treat certain types of epilepsy when other medications are not suitable.

Berat Molekul

204,2200 g/mol

LogP

1,00

TPSA

49,40 Å²

Lipinski RO5

Lulus

Mekanisme Kerja

Modulates neuronal excitability through one or more mechanisms including blockade of voltage-gated sodium channels, enhancement of GABAergic inhibition, or modulation of calcium channels. This reduces the frequency and severity of seizure activity.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanisme

Modulates neuronal excitability through one or more mechanisms including blockade of voltage-gated sodium channels, enhancement of GABAergic inhibition, or modulation of calcium channels. This reduces the frequency and severity of …

Struktur 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CCN1C(=O)NC(c2ccccc2)C1=O

InChI

InChI=1S/C11H12N2O2/c1-2-13-10(14)9(12-11(13)15)8-6-4-3-5-7-8/h3-7,9H,2H2,1H3,(H,12,15)

Molecular Formula

C11H12N2O2

HBD / HBA

1 / 2

Ikatan yang Dapat Dirotasi

2

Atom Berat

15

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

This hydantoin anticonvulsant stabilizes nerve cell membranes to reduce the spread of abnormal electrical activity that causes seizures. It is used to treat certain types of epilepsy when other medications are not suitable.

Modulates neuronal excitability through one or more mechanisms including blockade of voltage-gated sodium channels, enhancement of GABAergic inhibition, or modulation of calcium channels. This reduces the frequency and severity of seizure activity.

Yes, Ethotoin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1095. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 3292. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Mencari informasi yang ramah bagi pasien?

Ethotoin di PillFYI

Struktur

Data Cepat

Rumus: C11H12N2O2

Tautan Eksternal

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.